Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 7 years
- Director since
- 2023
7 years of board service in total across 2 boards, counting each seat separately. Longest: ARS Pharmaceuticals Inc., 3 years.
ARS Pharmaceuticals Inc.
Director
Relay Therapeutics Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Apr 7, 2025 | ARS Pharmaceuticals Inc. | Option exercise | +22,509 | $4.85 | $109,169 |
| Apr 7, 2025 | ARS Pharmaceuticals Inc. | Option exercise | +27,493 | $4.85 | $133,341 |
| Apr 7, 2025 | ARS Pharmaceuticals Inc. | Open-market sale | −50,002 | $12.30 | $615,025 |
| Mar 6, 2025 | ARS Pharmaceuticals Inc. | Option exercise | +49,600 | $4.85 | $240,560 |
| Mar 6, 2025 | ARS Pharmaceuticals Inc. | Open-market sale | −49,600 | $11.21 | $556,016 |
| Mar 5, 2025 | ARS Pharmaceuticals Inc. | Option exercise | +400 | $4.85 | $1,940 |
| Mar 5, 2025 | ARS Pharmaceuticals Inc. | Open-market sale | −400 | $11.00 | $4,400 |
| Feb 3, 2025 | ARS Pharmaceuticals Inc. | Option exercise | +9,064 | $3.15 | $28,552 |
| Feb 3, 2025 | ARS Pharmaceuticals Inc. | Option exercise | +40,936 | $4.85 | $198,540 |
| Feb 3, 2025 | ARS Pharmaceuticals Inc. | Open-market sale | −50,000 | $12.31 | $615,500 |
| Jan 6, 2025 | ARS Pharmaceuticals Inc. | Option exercise | +50,000 | $3.15 | $157,500 |
| Jan 6, 2025 | ARS Pharmaceuticals Inc. | Open-market sale | −50,000 | $11.10 | $555,000 |
| Dec 4, 2024 | ARS Pharmaceuticals Inc. | Option exercise | +14,772 | $3.15 | $46,532 |
| Dec 4, 2024 | ARS Pharmaceuticals Inc. | Open-market sale | −14,772 | $13.75 | $203,115 |
| Dec 3, 2024 | ARS Pharmaceuticals Inc. | Option exercise | +25,606 | $1.27 | $32,520 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.